Examples of 'subcutaneous formulation' in a sentence
Meaning of "subcutaneous formulation"
Subcutaneous formulation relates to a method of administering medication or treatment by injecting it into the layer of tissue just beneath the skin. This method allows for the slow release of the medication into the bloodstream over a period of time
How to use "subcutaneous formulation" in a sentence
Basic
Advanced
subcutaneous formulation
Herceptin subcutaneous formulation in administration system is ready to use.
Adverse reactions reported in MabThera subcutaneous formulation usage.
Herceptin subcutaneous formulation was locally and systemically well tolerated.
Switch from intramuscular to subcutaneous formulation.
RoActemra subcutaneous formulation is not intended for intravenous administration.
Each protein was administered as a subcutaneous formulation.
Applies to subcutaneous formulation only.
Description of selected adverse reactions with the subcutaneous formulation.
Clinical experience of MabThera subcutaneous formulation in chronic lymphocytic leukaemia.
A subcutaneous formulation may be prepared as follows,.
Switching treatment between trastuzumab intravenous and trastuzumab subcutaneous formulation and vice versa.
Rituximab subcutaneous formulation.
Switching treatment between Herceptin intravenous and Herceptin subcutaneous formulation and vice versa.
MabThera subcutaneous formulation MabThera intravenous formulation.
Furthermore, we plan to pursue a subcutaneous formulation.
See also
However, the subcutaneous formulation tested exhibited less myelosuppression and faster recovery.
For example, rituximab is used in chronic lymphocytic leukemia as a subcutaneous formulation.
The interval between consecutive Herceptin subcutaneous formulation administrations should not be less than three weeks.
The estimated median terminal elimination half-life of MabThera subcutaneous formulation was.
MabThera subcutaneous formulation.
Some adverse events / reactions were reported with a higher frequency for the subcutaneous formulation.
Clinical experience of MabThera subcutaneous formulation in Non-Hodgkin's lymphoma.
Alternatively, the container may be a pre-filled syringe containing, for example, the subcutaneous formulation.
Of patients treated with Herceptin subcutaneous formulation developed antibodies against the excipient hyaluronidase rHuPH20.
Administration-related reactions ( ARRs ) are known to occur with Herceptin subcutaneous formulation.
The recommended dose for Herceptin subcutaneous formulation is 600 mg irrespective of the patient 's body weight.
For instructions on use and handling of Herceptin subcutaneous formulation refer to section 6.6.
MabThera subcutaneous formulation was given at a fixed dose of 1400 mg.
The bioavailability for the subcutaneous formulation was 79.
MabThera 1400 mg subcutaneous formulation should be administered as subcutaneous injection only, over approximately 5 minutes.
The recommended dose for Remsima subcutaneous formulation is 120 mg once every 2 weeks.
Formulation Example 9 A subcutaneous formulation may be prepared as follows,.
Results - Summary Administration of a subcutaneous formulation of hu 1124 was well-tolerated at the site of injection.
You'll also be interested in:
Examples of using Subcutaneous
Show more
This is the subcutaneous drug delivery pump
Diseases of the skin and the subcutaneous
Remaining subcutaneous fat deposits are removed completely
Examples of using Formulation
Show more
Reduction in budget formulation cycle time assessed
Formulation and communication of conditional interpretative declarations
Child rights policy formulation and coordination
